10% Owner Sells $292K in Clene Inc. Stock
CLNN has more than doubled off its 52-week low of $2.28.
Summary
A 10% owner of Clene Inc. sold approximately $292,184 worth of common stock in open market transactions, reducing their stake.
Key Events · Ownership and Investor Activity · CLNN
-
10% Owner Sells Shares
Ugwumba Chidozie, a 10% owner of Clene Inc., disposed of 58,289 shares of common stock through open market sales.
-
Significant Transaction Value
The sales totaled approximately $292,184 across three transactions between January 13 and January 15, 2026, with prices ranging from $4.89 to $5.12 per share.
-
Post-Transaction Holdings
Following these sales, Ugwumba Chidozie (via Symbiosis II, LLC) holds 650,298 shares of Clene Inc. common stock.
Analysis · CLNN · Life Sciences
The open market sales by a 10% owner, while not an operational insider, represent a notable reduction in their investment in Clene Inc. The transaction value of nearly $300,000 is significant for a micro-cap company, potentially signaling a lack of conviction or a move to rebalance their portfolio. Investors should monitor future insider activity and company developments.
How filings like this one have moved
In the 30 days to Sep 21, 2026, 29.2% of the 1541 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLNN was trading at $4.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $58.3M. The 52-week trading range was $2.28 to $13.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.